Refining Risk Stratification in RAS-Positive Thyroid Nodules: Clinical and Molecular Insights from a Large Surgical Cohort
In 585 RAS-mutated thyroid nodules, distinct molecular and clinical features predict malignancy risk and guide surgical management, with isolated RAS mutations showing low recurrence and potential for conservative care.